(FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 43.80%-333.28K | 69.32%-42.44K | 87.73%-45.52K | -212.12%-126.68K | -174.98%-118.65K | -593K | -229.07%-138.34K | -218.87%-370.93K | -166.84%-40.59K | -43.15K |
Net income from continuing operations | -40.09%-612.58K | 53.71%-94.06K | 35.05%-77.42K | -239.36%-213.13K | -337.73%-227.96K | ---437.29K | -251.21%-203.21K | 19.68%-119.2K | -228.66%-62.8K | ---52.08K |
Operating gains losses | ---92.6K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Asset impairment expenditure | --69.1K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Remuneration paid in stock | --0 | ---- | ---- | ---- | ---- | --42.75K | ---- | ---- | ---- | ---- |
Change In working capital | 252.57%302.79K | 239.59%75.12K | 112.67%31.9K | 289.13%86.46K | 1,123.87%109.32K | ---198.47K | 39.83%22.12K | -884.64%-251.74K | 469.84%22.22K | --8.93K |
-Change in receivables | 102.53%382 | 389.80%20.88K | 9.53%-6.75K | -277.12%-18.13K | 0.83%4.38K | ---15.13K | -495.37%-7.2K | -1,863.16%-7.46K | 31.09%-4.81K | --4.35K |
-Change in prepaid assets | 172.55%111.34K | -294.53%-20.74K | 103.08%5.06K | 170.84%17.3K | 1,817.30%109.72K | ---153.47K | --10.66K | ---164.13K | --6.39K | ---6.39K |
-Change in payables and accrued expense | 739.64%191.07K | 301.78%74.99K | 141.91%33.59K | 322.95%87.28K | -143.59%-4.78K | ---29.87K | -1.93%18.66K | -346.89%-80.15K | 89.76%20.64K | --10.98K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 43.80%-333.28K | 69.32%-42.44K | 87.73%-45.52K | -212.12%-126.68K | -174.98%-118.65K | ---593K | -229.07%-138.34K | -218.87%-370.93K | -166.84%-40.59K | ---43.15K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 120.00%10K | 220.00%60K | 0 | -50K | -50K | 0 | ||||
Net PPE purchase and sale | 120.00%10K | 220.00%60K | --0 | ---- | ---- | ---50K | ---50K | --0 | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 120.00%10K | 220.00%60K | --0 | ---- | ---- | ---50K | ---50K | --0 | ---- | ---- |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -97.16%20K | 0 | -97.31%20K | 0 | 0 | 703.56K | 0 | 85.64%742.54K | 0 | -38.98K |
Net common stock issuance | --0 | --0 | ---- | ---- | ---- | --982.97K | --0 | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | --20K | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---279.41K | --0 | ---240.43K | --0 | ---38.98K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -97.16%20K | --0 | -97.31%20K | --0 | --0 | --703.56K | --0 | 85.64%742.54K | --0 | ---38.98K |
Net cash flow | ||||||||||
Beginning cash position | 23.11%322.55K | -99.67%1.7K | -80.45%27.22K | 13.36%203.9K | 23.11%322.55K | --261.99K | 49.86%510.88K | 143.38%139.28K | --179.86K | --261.99K |
Current changes in cash | -600.84%-303.28K | 109.32%17.56K | -106.87%-25.52K | -335.31%-176.68K | -44.46%-118.65K | --60.56K | -138.68%-188.34K | 31.00%371.61K | -170.92%-40.59K | ---82.13K |
End cash Position | -94.03%19.26K | -94.03%19.26K | -99.67%1.7K | -80.45%27.22K | 13.36%203.9K | --322.55K | 23.11%322.55K | 49.86%510.88K | 143.38%139.28K | --179.86K |
Free cash from | 40.39%-383.28K | 77.47%-42.44K | 87.73%-45.52K | -335.31%-176.68K | -174.98%-118.65K | ---643K | -348.00%-188.34K | -218.87%-370.93K | 19.17%-40.59K | ---43.15K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data